247 related articles for article (PubMed ID: 25639486)
1. Tumour suppressor TRIM33 targets nuclear β-catenin degradation.
Xue J; Chen Y; Wu Y; Wang Z; Zhou A; Zhang S; Lin K; Aldape K; Majumder S; Lu Z; Huang S
Nat Commun; 2015 Feb; 6():6156. PubMed ID: 25639486
[TBL] [Abstract][Full Text] [Related]
2. Role of TRIM33 in Wnt signaling during mesendoderm differentiation.
Xia X; Zuo F; Luo M; Sun Y; Bai J; Xi Q
Sci China Life Sci; 2017 Oct; 60(10):1142-1149. PubMed ID: 28844090
[TBL] [Abstract][Full Text] [Related]
3. Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in glioma.
Verma BK; Kondaiah P
J Neurooncol; 2020 Sep; 149(2):209-217. PubMed ID: 32803659
[TBL] [Abstract][Full Text] [Related]
4. Human Neuralized is a novel tumour suppressor targeting Wnt/β-catenin signalling in colon cancer.
Yi JM; Kang TH; Han YK; Park HY; Yang JH; Bae JH; Suh JS; Kim TJ; Kim JG; Cui YH; Suzuki H; Kumegawa K; Kim SJ; Zhao Y; Park IJ; Hong SM; Chung JY; Lee SJ
EMBO Rep; 2023 Aug; 24(8):e56335. PubMed ID: 37341560
[TBL] [Abstract][Full Text] [Related]
5. Nuclear β-catenin expression is positively regulated by JAB1 in human colorectal cancer cells.
Nishimoto A; Takemoto Y; Saito T; Kurazumi H; Tanaka T; Harada E; Shirasawa B; Hamano K
Biochem Biophys Res Commun; 2020 Dec; 533(3):548-552. PubMed ID: 32977947
[TBL] [Abstract][Full Text] [Related]
6. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
7. E3 ubiquitin ligase Trim33 ubiquitylates Annexin A2 to promote NF-κB induced skin inflammation in psoriasis.
Zhang J; Zhu J; Chen X; Xia H; Yang L
J Dermatol Sci; 2022 Sep; 107(3):160-168. PubMed ID: 36096861
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
9. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice.
Yang X; Wood PA; Ansell CM; Ohmori M; Oh EY; Xiong Y; Berger FG; Peña MM; Hrushesky WJ
J Biochem; 2009 Mar; 145(3):289-97. PubMed ID: 19106159
[TBL] [Abstract][Full Text] [Related]
11. Tripartite motif containing 33 demonstrated anticancer effect by degrading c‑Myc: Limitation of glutamine metabolism and proliferation in endometrial carcinoma cells.
Qi Y; Ma N; Zhang J
Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37859625
[TBL] [Abstract][Full Text] [Related]
12. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system.
Sadot E; Simcha I; Iwai K; Ciechanover A; Geiger B; Ben-Ze'ev A
Oncogene; 2000 Apr; 19(16):1992-2001. PubMed ID: 10803460
[TBL] [Abstract][Full Text] [Related]
13. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis.
Cong F; Zhang J; Pao W; Zhou P; Varmus H
BMC Mol Biol; 2003 Sep; 4():10. PubMed ID: 14516475
[TBL] [Abstract][Full Text] [Related]
14. The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the β-Catenin Coactivator BCL9-2 in Breast Cancer Cells.
El-Hage P; Petitalot A; Monsoro-Burq AH; Maczkowiak F; Driouch K; Formstecher E; Camonis J; Sabbah M; Bièche I; Lidereau R; Lallemand F
Mol Cancer Res; 2015 May; 13(5):902-12. PubMed ID: 25678599
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase TRIM21 targets TIF1γ to regulate β-catenin signaling in glioblastoma.
Li Y; Bao L; Zheng H; Geng M; Chen T; Dai X; Xiao H; Yang L; Mao C; Qiu Y; Xu Y; Wang D; Li MX; Chen Q
Theranostics; 2023; 13(14):4919-4935. PubMed ID: 37771771
[No Abstract] [Full Text] [Related]
16. Macrophage production and activation are dependent on TRIM33.
Gallouet AS; Ferri F; Petit V; Parcelier A; Lewandowski D; Gault N; Barroca V; Le Gras S; Soler E; Grosveld F; Davidson I; Romeo PH
Oncotarget; 2017 Jan; 8(3):5111-5122. PubMed ID: 27974684
[TBL] [Abstract][Full Text] [Related]
17. TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation.
Ferri F; Parcelier A; Petit V; Gallouet AS; Lewandowski D; Dalloz M; van den Heuvel A; Kolovos P; Soler E; Squadrito ML; De Palma M; Davidson I; Rousselet G; Romeo PH
Nat Commun; 2015 Nov; 6():8900. PubMed ID: 26592194
[TBL] [Abstract][Full Text] [Related]
18. Trim33 is required for appropriate development of pre-cardiogenic mesoderm.
Rajderkar S; Mann JM; Panaretos C; Yumoto K; Li HD; Mishina Y; Ralston B; Kaartinen V
Dev Biol; 2019 Jun; 450(2):101-114. PubMed ID: 30940539
[TBL] [Abstract][Full Text] [Related]
19. Generation of mice with a conditional allele for Trim33.
Kim J; Kaartinen V
Genesis; 2008 Jun; 46(6):329-33. PubMed ID: 18543301
[TBL] [Abstract][Full Text] [Related]
20. Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma.
Herquel B; Ouararhni K; Khetchoumian K; Ignat M; Teletin M; Mark M; Béchade G; Van Dorsselaer A; Sanglier-Cianférani S; Hamiche A; Cammas F; Davidson I; Losson R
Proc Natl Acad Sci U S A; 2011 May; 108(20):8212-7. PubMed ID: 21531907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
